Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)

SHA:603707 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,372	1,024	1,210	1,389	658.55	493.55
Trading Asset Securities	591.5	1,055	681.99	1.3	259.8	845.79
Cash & Short-Term Investments	1,964	2,080	1,892	1,390	918.35	1,339
Cash Growth	-12.48%	9.94%	36.12%	51.34%	-31.43%	210.56%
Accounts Receivable	1,288	920.04	771.68	974.11	897.75	788.11
Other Receivables	250.26	273.46	230.88	241.94	167.88	107.21
Receivables	1,538	1,194	1,003	1,216	1,066	895.31
Inventory	3,391	3,675	4,158	5,616	4,894	4,457
Prepaid Expenses	4.99	13.17	11.98	8.46	7.98	10.11
Other Current Assets	91.58	84.42	196.99	64.14	43.62	65.9
Total Current Assets	6,989	7,046	7,262	8,294	6,930	6,768
Property, Plant & Equipment	1,194	1,197	1,235	1,198	827.42	532.83
Long-Term Investments	83.04	83.26	72.48	61.6	26.39	3.26
Goodwill	128.97	129.51	127.61	125.48	114.87	117.56
Other Intangible Assets	349.87	337.53	174.1	118.96	123.85	105.37
Long-Term Deferred Tax Assets	176.79	203.25	348.4	101.47	34.54	21.65
Long-Term Deferred Charges	736.9	459.55	294.24	94.62	77.65	55.52
Other Long-Term Assets	33.75	53.7	10.38	16.31	82.34	116.08
Total Assets	9,692	9,510	9,524	10,010	8,217	7,720
Accounts Payable	584.3	495.66	537.74	505.12	458.87	502.22
Accrued Expenses	237.47	207.11	294.85	88.15	64.56	47.26
Short-Term Debt	1,187	1,236	1,567	1,957	1,571	2,132
Current Portion of Long-Term Debt	530.53	8.21	505.45	0.42	-	-
Current Income Taxes Payable	4	3.72	29.31	0.44	8.73	17.42
Current Unearned Revenue	39.26	59.03	35.93	38.22	25.07	29.08
Other Current Liabilities	43.5	54.67	116.18	115.44	138.56	77.65
Total Current Liabilities	2,626	2,064	3,086	2,705	2,266	2,806
Long-Term Debt	321.17	824.16	512.37	997.36	480.75	1,132
Long-Term Leases	28.36	10.28	13.23	15.94	-	-
Long-Term Unearned Revenue	82.62	84.63	76.57	84.99	65.51	38.15
Long-Term Deferred Tax Liabilities	31.83	38.28	37.33	39.99	1.42	-
Total Liabilities	3,090	3,022	3,726	3,843	2,814	3,976
Common Stock	1,616	1,616	1,617	1,617	1,244	934.16
Additional Paid-In Capital	587.29	587.29	601.02	603.59	987.96	157.77
Retained Earnings	4,329	4,204	3,540	3,915	3,123	2,485
Treasury Stock	-10.22	-	-27.75	-32.82	-47.3	-14.43
Comprehensive Income & Other	84.11	84.62	72.5	67.9	70.45	159.79
Total Common Equity	6,606	6,492	5,802	6,171	5,378	3,722
Minority Interest	-3.52	-3.51	-3.47	-3.47	24.84	22.12
Shareholders' Equity	6,602	6,488	5,798	6,167	5,403	3,745
Total Liabilities & Equity	9,692	9,510	9,524	10,010	8,217	7,720
Total Debt	2,067	2,079	2,598	2,971	2,051	3,264
Net Cash (Debt)	-103.33	1.13	-706.06	-1,581	-1,133	-1,925
Net Cash Per Share	-0.06	0.00	-0.45	-0.97	-0.72	-1.21
Filing Date Shares Outstanding	1,486	1,616	1,473	1,653	1,543	1,662
Total Common Shares Outstanding	1,486	1,616	1,473	1,653	1,543	1,662
Working Capital	4,363	4,981	4,175	5,589	4,663	3,962
Book Value Per Share	4.44	4.02	3.94	3.73	3.49	2.24
Tangible Book Value	6,127	6,025	5,500	5,926	5,139	3,500
Tangible Book Value Per Share	4.12	3.73	3.73	3.58	3.33	2.11
Buildings	474.18	472.9	481.48	448.47	268.49	164.68
Machinery	1,368	1,323	1,279	981.72	751.74	606.4
Construction In Progress	136.65	137.44	79.74	250.62	215.26	99.68

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.